Key result
Maternal diclofenac therapy at 35 weeks of gestation led to premature closure of the ductus arteriosus, requiring immediate Cesarean section for an excellent neonatal outcome.
Case Report (n=1)
Maternal use of diclofenac in the third trimester can cause premature closure of the fetal ductus arteriosus and should be avoided.
Answers are grounded in this paper and cite their sources.
May signal third-trimester diclofenac risk to fetal ductus; leaves open need for prospective NSAID safety data.
We report a case of prenatal diagnosis of premature closure of the ductus arteriosus following maternal diclofenac therapy at 35 weeks of gestation. Fetal echocardiography at 37 weeks of gestation revealed a dilated right ventricle with moderate tricuspid regurgitation, pulmonary insufficiency and complete closure of the ductus arteriosus. Immediate Cesarean section resulted in an excellent neonatal outcome. Whereas the effect of indomethacin on prenatal ductal constriction is well known, widely prescribed non-steroidal anti-inflammatory drugs such as diclofenac can have an equally deleterious effect and are best avoided in the third trimester of pregnancy.
No takes yet. Share an insight, caveat, or question.
Auer et al. (2004) conducted a case report in Premature closure of the ductus arteriosus (n=1). Maternal diclofenac therapy was evaluated on Fetal echocardiographic findings and neonatal outcome. Maternal diclofenac therapy at 35 weeks of gestation led to premature closure of the ductus arteriosus, requiring immediate Cesarean section for an excellent neonatal outcome.
Synapse has enriched 10 related papers. Consider them for comparative context: